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Transcription factors (TFs) and their specific interac-
tions with targets are crucial for specifying gene-
expression programs. To gain insights into the tran-
scriptional regulatory networks in embryonic stem
(ES) cells, we use chromatin immunoprecipitation
coupled with ultra-high-throughput DNA sequencing
(ChIP-seq) to map the locations of 13 sequence-
specific TFs (Nanog, Oct4, STAT3, Smad1, Sox2,
Zfx, c-Myc, n-Myc, Klf4, Esrrb, Tcfcp2l1, E2f1, and
CTCF) and 2 transcription regulators (p300 and
Suz12). These factors are known to play different
roles in ES-cell biology as components of the LIF
and BMP signaling pathways, self-renewal regula-
tors, and key reprogramming factors. Our study
provides insights into the integration of the signaling
pathways into the ES-cell-specific transcription cir-
cuitries. Intriguingly, we find specific genomic re-
gions extensively targeted by different TFs. Collec-
tively, the comprehensive mapping of TF-binding
sites identifies important features of the trans-
criptional regulatory networks that define ES-cell
identity.
INTRODUCTION
Embryonic stem (ES) cells are derived from early preimplantation
embryos, and they can be maintained for extended periods
of time in culture through self-renewing division (Smith, 2001).
These cells are pluripotent, as they retain the ability to differenti-
ate into many, and perhaps all, cell lineages. The ability to gen-
erate transgenic mouse ES cells through homologous recombi-
nation has revolutionized biological research through the1106 Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc.creation of genetically altered animals (Thomas and Capecchi,
1986). In addition, human ES cells can potentially serve as an
inexhaustible source of cells for the derivation of clinically useful
cells for regenerative medicine and cell-based therapy.
Mouse ES cells were first isolated in 1981 from mouse blasto-
cysts (Smith, 2001). Maintenance of the self-renewing state of
mouse ES cells requires the cytokine leukemia inhibitory factor
(LIF). The binding of LIF to its receptor activates STAT3 through
phosphorylation (Niwa et al., 1998). LIF alone, however, is not
sufficient to maintain ES cells, as their maintenance requires
the presence of fetal calf serum. Bone morphogenetic proteins
(BMPs) appear to be key serum-derived factors that act in con-
junction with LIF to enhance the self-renewal and pluripotency of
mouse ES cells (Ying et al., 2003). The binding of BMP4 to its
receptors triggers the phosphorylation of Smad1 and activates
the expression of members of the Id (inhibitor of differentiation)
gene family. As ES cells overexpressing Ids can self-renew in
the absence of BMP4, it is proposed that induction of Id expres-
sion is the critical contribution of the BMP/Smad pathway.
Hence, the LIF and BMP signaling pathways play a central role
in the maintenance of a pluripotential stem cell phenotype.
Besides these signaling pathways, which sense the presence
of extrinsic growth factors in the environment, intrinsic factors
such as transcription factors (TFs) are also essential for specify-
ing the undifferentiated state of ES cells. Oct4, encoded by
Pou5f1, is a POU domain-containing TF known to be essential
to ES cells and early embryonic development (Boiani and
Scho¨ler, 2005; Nichols et al., 1998; Smith, 2001). Oct4 interacts
with Sox2 (an HMG-containing TF), and genome-wide mapping
of OCT4 and SOX2 sites in human ES cells shows that they
cotarget multiple genes (Boyer et al., 2005). The cis-regulatory
element to which the Sox2-Oct4 complex is bound consists of
neighboring sox (50-CATTGTA-30) and oct (50-ATGCAAAT-30)
elements (Loh et al., 2006). Recent works indicate that Oct4
and Sox2, along with c-Myc and Klf4, are sufficient for repro-
gramming fibroblasts to induced pluripotent stem cells (iPS),
which are functionally similar to ES cells (Maherali et al., 2007;
Okita et al., 2007; Takahashi and Yamanaka, 2006; Wernig
et al., 2007). Hence, these TFs can exert a dominant role in re-
constructing the transcriptional regulatory network of ES cells.
A thirdwell-studied TF in ES cells is Nanog. Nanog is a homeodo-
main-containing TF that can sustain pluripotency in ES cells even
in the absence of LIF (Chambers et al., 2003; Mitsui et al., 2003).
Other transcriptional regulators are required as well to maintain
ES cells. Recent work has begun to identify new components
of the transcriptional regulatory network required for the mainte-
nance of pluripotency. Through genetic studies, Esrrb and Zfx
have been shown to regulate the self-renewal of ES cells (Iva-
nova et al., 2006; Loh et al., 2006; Galan-Caridad et al., 2007).
Despite the critical roles of transcriptional regulators in the
maintenance of mouse ES cells, detailed knowledge of their in
vivo targets is lacking. The targets of the downstream effectors
of key signaling pathways are poorly studied, and the targets
ofmany of the TFs in ES cells have not been defined. Themanner
in which the different transcriptional circuitries are integrated is
also not clear. Elucidation of the transcriptional regulatory net-
works that are operating in ES cells is fundamental for under-
standing the molecular nature of pluripotency, self-renewal,
and reprogramming.
In this study, we use chromatin immunoprecipitation coupled
with massively parallel short-tag-based sequencing (ChIP-seq)
(Barski et al., 2007; Johnson et al., 2007; Mikkelsen et al.,
2007; Robertson et al., 2007) to map the in vivo binding loci for
13 sequence-specific TFs and 2 transcription coregulators in liv-
ing mouse ES cells. Intriguingly, these TFs are wired to the ES-
cell genome in two major ways. The first cluster includes Nanog,
Oct4, Sox2, Smad1, and STAT3. The second cluster consists of
c-Myc, n-Myc, Zfx, and E2f1. The coactivator p300 is predomi-
nantly recruited to dense binding loci involving proteins found
in the first type of cluster. Our analysis also reveals that highly
dense binding loci involving these factors have characteristic
features of enhanceosomes. ES-cell-specific gene expression
is associated with binding of many of the factors studied. Based
on these associations between binding and expression, we have
constructed a transcriptional regulatory network model that
integrates the two key signaling pathways with the intrinsic fac-
tors in ES cells.
RESULTS
Mapping of In Vivo Binding Sites of 13 Transcription
Factors by Using ChIP-seq
Whole-genome binding sites of 13 sequence-specific transcrip-
tion factors (TFs) were profiled in mouse ES cells by using the
ChIP-seq approach (Barski et al., 2007; Johnson et al., 2007;
Mikkelsen et al., 2007; Robertson et al., 2007). Nanog, Oct4,
Sox2, Esrrb, and Zfx are known regulators of pluripotency and/
or self-renewal. Smad1 and STAT3 are key components of the
signaling pathways mediated by BMP and LIF, respectively.
Tcfcp2l1 is preferentially upregulated in ES cells but has unchar-
acterized DNA-binding properties and function (Ivanova et al.,
2006). E2F1 is best known for its role in regulating cell-cycle
progression and has also been shown to associate extensively
with promoter regions (Bieda et al., 2006). Klf4 and Myc TFsare reprogramming factors that are also implicated in the main-
tenance of the undifferentiated state of ES cells (Cartwright et al.,
2005; Jiang et al., 2008). CTCF is required for transcriptional in-
sulation (Kim et al., 2007). Through mapping the binding sites of
these 13 TFs, we seek to investigate the binding behavior of
these factors and to uncover insights into how they are wired
in the ES-cell genome. Here, chromatin immunoprecipitation
(ChIP) with specific antibodies against these TFs was used to
enrich the DNA fragments bound by these TFs, followed by di-
rect ultra-high-throughput sequencing with the Solexa Genome
Analyzer platform. Genomic regions defined bymultiple overlap-
ping DNA fragments derived from the ChIP enrichments were
considered as putative binding sites. We used Monte Carlo sim-
ulations to determine the minimal number of overlapping ChIP
fragment reads required to distinguish true binding from nonspe-
cific, randomly expected overlaps. Regions with overlapping
ChIP DNA counts higher than the threshold were further filtered
by removing peaks that were also found in the negative control
(anti-GFP ChIP) library. ChIP-qPCR validations were carried
out on randomly selected sites with different ‘‘intensities’’ (i.e.,
ChIP tag counts within the defined overlap region) to further re-
fine the threshold used. Based on the ChIP-qPCR analyses,
we determined that the specificity of binding site determination
was greater than 95% for the majority of the libraries. We identi-
fied between 1,126 and 39,609 TF-binding sites (TFBSs) for the
13 factors. As examples, the binding profiles for all 13 factors at
thePou5f1 (Oct4) andNanog gene loci are shown in Figure 1. The
specificity of the antibodies, the depth and coverage of sequenc-
ing, ChIP-qPCR validation data, and detailed bioinformatics
analyses can be found in the Supplemental Data available with
this article online.
Motif Analyses of TFBSs
To determine the in vivo sequence specificity of these TFs, we
derived the consensus sequence motifs by using a de novo
motif-discovery algorithm (as described by Loh et al., 2006). Se-
quences (±100 bp) from the top 500 binding peakswere selected
from each factor, repeats were masked, and the program
Weeder (Pavesi et al., 2001) was used to find overrepresented
sequences. Because of the high resolution in defining the bind-
ing sites offered by the high sequence depth coverage, overrep-
resented motifs could be uncovered from 12 of the 13 factors
(excluding E2f1) (Figure 2). Consistent with our previous study,
we obtained a sox-oct composite element consisting of
a Sox2-binding site consensus (50-CATTGTT-30) and a canonical
Oct4-binding sequence (5-0ATGCAAAT-30) adjacent to one an-
other from both the Oct4 and Sox2 data sets (Loh et al., 2006).
The presence of a common motif suggests that the Sox2 and
Oct4 heterodimer is the functional binding unit. Interestingly,
the de novo-predicted matrices for Nanog- and Smad1-bound
sequences resemble the sox-oct joint motif. This reflects the fre-
quent co-binding of Nanog and Smad1 with Sox2 and Oct4. It is
noteworthy that the Nanog motif reported previously (Loh et al.,
2006) can be found by using another motif-discovery algorithm,
NestedMICA (see Figure S5 available online). The binding
consensus sequences identified for Klf4, Esrrb, CTCF, c-Myc,
n-Myc, STAT3, and Zfx are closely related to the binding se-
quences reported previously (Ehret et al., 2001; Galan-CaridadCell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc. 1107
et al., 2007; Kaczynski et al., 2003; Kim et al., 2007; Pettersson
et al., 1996; Zeller et al., 2006). Hence, we showed that sequence
motifs can be identified from the in vivo-bound sites.
A Subset of Multiple Transcription-Factor-Binding Loci
as ES-Cell Enhanceosomes
Upon close examination of the binding profiles from these 13
TFs, we found that a subset of binding sites was bound by
many of these TFs. To investigate their biological relevance,
we first determined the significance of such enrichments of
TFBSs (see Supplemental Experimental Procedures). Peak sites
within 100 bp were iteratively clustered to define multiple tran-
scription factor-binding loci (MTL) (see Table S8). The number
Figure 1. Genome-Wide Mapping of 13 Factors
in ES Cells by Using ChIP-seq Technology
TFBS profiles for the sequence-specific transcription
factors and mock ChIP control at the Pou5f1 and
Nanog gene loci are shown.
of these MTL, plotted as a function of the
number of different TFs in the MTL, is shown
in Figure 3A. Loci bound by 4 ormore TFs are
highly significant (p < 0.001, Figure 3A), and
there is a total of 3583 such MTL. Of these,
1440 loci (40.2%) were found in the inter-
genic regions, and the remaining loci were
spread between promoter regions (1334
loci, 37.2%) and within gene regions (809
loci, 22.6%). Less than 20% of the clusters
with 7 or more TFs are found at promoter re-
gions (yellow columns, Figure 3B), compared
with 40%of the clusters that have fewer than
5 TFs. Hence, the co-occurrence of TFBSs
within the MTL is not mainly due to their oc-
currence at promoters.
To further dissect the composition of the
MTL, we examined the co-occupancy of dif-
ferent factors found in the 3583 MTL. Among
the 13 TFs, Nanog, Sox2, Oct4, Smad1, and
STAT3 (blue box, Figure 4A) tend to co-occur
quite often, as do members of a second, dis-
tinct group comprised of n-Myc, c-Myc,
E2f1, and Zfx (green box, Figure 4A). In addi-
tion to these two high-level groupings of TFs,
we find it useful to define four groups of MTL
based on the presence or absence of binding
sites of (i) Oct4, Sox2, or Nanog and (ii)
c-Myc or n-Myc. The Nanog-Oct4-Sox2
clusters (binding observed for Nanog, Oct4,
or Sox2, but not for n-Myc or c-Myc) consti-
tute 43.4% of the 3583 MTL (orange sector,
Figure 4B). The Myc-specific clusters (n-
Myc or c-Myc, but not Nanog, Oct4, or
Sox2) make up 32.9% of the MTL (light-
blue sector, Figure 4B).
Consistent with the pairwise co-occurrence shown in
Figure 4A, 87.4% of Smad1- and 56.8% of STAT3-binding sites
within MTL were associated with the Nanog-Oct4-Sox2-specific
MTL (orange sector, Figure 4C). This indicates that Smad1 and
STAT3 share many common target sites with Nanog, Oct4,
and Sox2 and reflects a point of convergence of the two key sig-
naling pathways (via Smad1 and STAT3) with the core circuitry
defined by Nanog, Oct4, and Sox2 (Boyer et al., 2005). This is
consistent with a previous study showing the link between
Nanog and the LIF pathway (Chambers et al., 2003). A total of
56.9% of Esrrb- and 41.9% of Klf4-binding sites within MTL
were found in theNanog-Oct4-Sox2-specificMTL. Indeed, Esrrb
has been shown to reside in the same complex as Nanog (Wang1108 Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc.
et al., 2006). In contrast, the co-occurrence of Zfx, CTCF, and
E2f1 was skewed toward the Myc-specific cluster (light-blue
sector, Figure 4C).
As the majority of the Nanog-Oct4-Sox2-specific MTL are
found outside of promoter regions (91.2%), we assayed genomic
sequences from this MTL cluster type for enhancer activity. A
total of 25 genomic fragments from the Nanog-Oct4-Sox2 clus-
ter and 8 genomic fragments from the Myc cluster were cloned
downstream of a luciferase reporter. The genomic fragment
was placed 2 kb away from the minimal Pou5f1 promoter used
to drive the luciferase gene. These constructs were transfected
into ES cells and 293T cells, and luciferase activity was mea-
sured. Remarkably, all 25 constructs with genomic fragments
spanning Nanog-Oct4-Sox2 clusters showed robust ES-cell-
specific enhancer activity (Figure 4D). A total of 21 of the con-
structs were even more active than a Nanog enhancer positive
control. In contrast, the control constructs with genomic frag-
ments from the Myc cluster were either not active or showed
very weak ES-cell-specific enhancer activity.
Combinatorial binding of TFs to enhancers can impart tran-
scriptional synergy (Struhl, 2001). To address the relationships
between Oct4, Smad1, and STAT3, we perturbed the binding
of these factors through RNAi or growth factor withdrawal. De-
pletion of Oct4 led to a reduction in Smad1 and STAT3 binding
(Figures 4E and 4F). The alteration of Smad1 and STAT3 binding
occurs specifically on Oct4, Smad1, and STAT3 co-bound sites
and was not due to a reduction in Smad1 and STAT3 levels (data
not shown). We also performed the reciprocal experiments of
withdrawing LIF or BMP4 from the culture media. LIF withdrawal
reduced STAT3 binding to its targets, whereas BMP4withdrawal
reduced Smad1 binding to its targets (Figures S3L and S3M).
Perturbation of the two signaling pathways, however, did not
affect the binding of Oct4 (Figure 4G). This indicates that Oct4
is pivotal in stabilizing the nucleoprotein complex and estab-
Figure 2. Identification of Enriched Motifs by Using
a De Novo Approach
Matrices predicted by the de novo motif-discovery algorithm
Weeder.
lishes a hierarchy of regulatory interactions be-
tween Oct4, STAT3, and Smad1. The mechanism
for Oct4-dependent STAT3 and Smad1 binding is
not clear. It is possible that Oct4 may interact with
STAT3 or Smad1 to facilitate their interactions with
chromatin.
In summary, through the global binding sites of
TF profiling, we uncovered over 3000 genomic
regions densely bound by TFs. The Nanog-Oct4-
Sox2 cluster exhibits features of enhanceosomes
by enhancing transcription from a distance and
shows extensive co-occupancy with Smad1 and
STAT3. Importantly, we showed that Oct4 is re-
quired for the binding of Smad1 and STAT3,
suggesting that Oct4 plays a pivotal role in stabilizing the TF
complex.
p300 Is Recruited to the Nanog-Oct4-Sox2 Cluster
To further assign functionality to the MTL, we determined the
locations of transcriptional coactivator p300 by using ChIP-seq
(Figures S6 and S7; Table S11). p300 is a histone acetyltransfer-
ase commonly found at enhancer regions (Heintzman et al.,
2007; Ogryzko et al., 1996). Genome-widemapping of a chroma-
tin regulator like p300 has the potential to reveal the DNA-binding
factor(s) responsible for recruiting the regulator to specific sites
in the genome (Birney et al., 2007). We also profiled the locations
of another chromatin regulator, Suz12, to serve as a control (Fig-
ures S6 and S7; Table S11).
Strikingly, p300 was found to co-occur with the Nanog-Oct4-
Sox2 cluster type (Figure 5A). Most p300-binding sites are asso-
ciated with 3–6 other TFs, up to as many as 9 in one case
(Figure 5B). The composition of these p300-containing clusters
is highly diverse, but, typically, they include one or more of the
factors Nanog, Oct4, or Sox2, followed, at lower probability, by
Smad1, Esrrb, Klf4, Tcfcp2l1, and STAT3 (Figure 5B). In contrast
to p300, Suz12 did not show strong association with any of the
13 TFs (data not shown). Using the de novo motif-discovery al-
gorithm Weeder, we were able to uncover an enriched motif
from p300-enriched sequences that resembles the sox-oct
composite element (Figure 5C). The association of p300 with
Nanog-Oct4-Sox2 clusters was validated for 12 sites by using
ChIP-qPCR. As controls, 12 Myc-bound MTL that lack p300 as
determined by the ChIP-seq assay also lack p300 as determined
by ChIP-qPCR. (Figure S8). These data suggest that Oct4, Sox2,
and Nanog are recruiting p300 to the genomic sites. To test this
hypothesis, we depleted Oct4, Sox2, or Nanog by RNAi and
checked for p300 binding. Our ChIP result showed that p300
binding was reduced by Oct4, Sox2, or Nanog depletionCell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc. 1109
(Figure 5D). Previous work has shown that c-Myc interacts with
p300 and mediates the recruitment of p300 to the hTERT pro-
moter (Faiola et al., 2005). In ES cells, we did not observe global
recruitment of p300 to Myc sites. Depletion of c-Myc by RNAi,
however, did not affect p300 recruitment to these sites (data
not shown). The data suggest that p300 could be a general factor
that is recruited to enhancers (Heintzman et al., 2007), and we
conclude that p300 recruitment is promoted by Oct4, Sox2,
and Nanog.
Combinatorial Binding of Transcription Factors
Is Associated with ES-Cell-Specific Expression
Next, we sought to establish the correlation between TF occu-
pancies and gene expression. A commonly employed approach
for assigning target genes to a TF is to associate TFBSs with
genes based on proximity. However, the relevant threshold for
proximity could be different for different TFs. For that reason,
we developed an approach to cluster genes based on TF-bind-
ing data (see the Supplemental Experimental Procedures). For
each pair of TF and gene, we assigned an association score
based on the genomic location of the binding site that is closest
to the transcription start site (TSS). This association score is
based on the distribution of the nearest site-to-TSS distances
in the genome and is thus different for, and characteristic of,
each TF. A higher score implies a higher chance of the gene
Figure 3. Multiple Transcription Factor-Binding Loci
(A) Plot of the number of transcription factors (TFs) bound per co-bound locus.
The distribution of randomly occurring co-bound loci is obtained by simulation.
(B) Distribution of clusters with different numbers of co-bound TFs. Promoter
regions are defined as sequences 2500 bp upstream and 500 bp downstream
of TSS (Heintzman et al., 2007).1110 Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc.being the target of the TF (Figure S9). This avoids an arbitrary
threshold. Based on the association scores for all TFs, we per-
formed k-means clustering to define five classes of genes that
are associated with a similar set of TFs (Figure 6A).
Class I genes are enriched in binding sites for Nanog, Oct4,
Sox2, Smad1, and STAT3 (Figure 6B). Class II genes are bound
heavily by c-Myc and n-Myc. Class III genes show enrichment
(more than 1-fold) in binding by n-Myc, Klf4, Esrrb, Tcfcp2l1,
Zfx, and E2f1. Class IV genes are highly enriched in Suz12-
bound genes, whereas class V genes are deficient in all TFs. In
total, 48% of genes are deficient in TF binding by the 13 TFs
(class IV and class V). We note that E2f1 and Suz12 localization
is essentially mutually exclusive, suggesting that Polycomb re-
pressor complexes inhibit the binding of E2f1 to its target sites.
Next, we analyzed the expression level of the genes found in
each class by using a published microarray data set for undiffer-
entiated ES cells (Ivanova et al., 2006), and we found that the
expression level is highest for genes in class II, followed by genes
in class I and class III. Genes in class IV and class V are either not
expressed or are expressed at a very low level in ES cells (Fig-
ure 6C; Supplemental Results and Discussion).
To further characterize the gene-expression profiles of each
class, we used a microarray data set that interrogated the tran-
scriptome dynamics of retinoic acid (RA)-induced differentiation
(Ivanova et al., 2006). The genes in this data set were divided into
three categories (see Supplemental Experimental Procedures):
genes upregulated in ES cells, nondifferentially expressed
genes, and genes downregulated in ES cells. Class I genes con-
stitute less than 10% of the nondifferentially expressed genes
and genes downregulated in ES cells (compare the red columns
in Figure 6D). This compares to 24% of the genes in the upregu-
lated category. The percentage of class II genes is only 12%
among nondifferentially expressed genes, but 36% in the upre-
gulated set (compare the blue columns in Figure 6D). Hence,
class I and class II genes are 2.7 (p = 8.14E-52)- and 2.9
(p = 1.28E-91)-fold enriched, respectively, in genes upregulated
in ES cells. In contrast, class IV and class V genes are underrep-
resented in this set. Class III is slightly enriched in genes that are
downregulated in ES cells, but not enriched in genes that are
preferentially upregulated in ES cells. As a validation, we com-
pared the five classes with another independent microarray
data set (Zhou et al., 2007), and similar results were obtained
(Figure S10). In summary, our global analysis showed that 60%
of genes upregulated in ES cells are from class I and class II.
Most importantly, the results demonstrate that gene clustering
based on TF occupancies has the potential to predict ES-cell-
specific gene expression. This suggests that the TF-binding pat-
terns of these two groups are relevant in specifying ES-cell-spe-
cific expression. In summary, we demonstrate that combinatorial
binding patterns of TFs have greater predictive power for ES-
cell-specific expression.
Constructing a Regulatory Network Defining ES-Cell-
Specific Expression
The self-renewing state of undifferentiated ES cells is character-
ized by the expression of genes specifically upregulated in this
cell type. We sought to construct a regulatory network that
specifies ES-cell-specific expression by using binding sites of
transcriptional regulators under the undifferentiated state. In or-
der to infer regulatory interactions, we made use of published
expression profiling data that compared undifferentiated with
differentiating ES cells. The rationale is that 9 (Nanog, Oct4,
Sox2, Klf4, n-Myc, c-Myc, Esrrb, Zfx, Tcfcp2l1) out of the 13
TFs we studied are known to be downregulated upon differenti-
ation or in differentiated cell types (Ivanova et al., 2002, 2006;
Ramalho-Santos et al., 2002). Two sets of published experi-
ments were used to define genes that are differentially ex-
pressed during differentiation (Ivanova et al., 2006; Zhou et al.,
2007). The use of two independently generated data sets mini-
mizes biases in gene-expression differences that are due to dif-
ferent ways of differentiating ES cells.
The regulatory interaction between a TF and its target gene is
first defined for an individual TF by intersecting the rank-ordered
bound genes (based on the total number of sequence tags asso-
ciatedwith binding site peaks) and the rank-ordered differentially
expressed genes (see Supplemental Data for method). The
thresholds for defining top-ranked genes in the two lists were
determined empirically by maximizing the number of genes in
the intersection subject to two constraints: there had to be at
least twice as many genes in the intersection as the number ex-
pected by chance, and the null model (that there are no genes in
excess) had to be rejected with p < 103. This method allows us
to make use of the unique features of our binding data sets (sig-
nal intensity and unbiased survey) and avoid the use of a single
cutoff for all data sets.
A network model based on the 13 TFs as depicted in Figure 7
reveals both anticipated and unanticipated aspects of the rela-
tionships between these TFs. Consistent with previous studies,
this model shows regulatory feedback loops for Oct4, Sox2,
and Nanog (Boyer et al., 2005; Chew et al., 2005; Loh et al.,
2006). An interesting feature of this network is the interconnectiv-
ity among 11 of the 13 TFs being profiled.
DISCUSSION
The Repertoire of Binding Sites in the Mammalian
Genome Revealed by Global Mapping of Transcription-
Factor-Binding Sites
Ultra-high-throughput sequencing technology through mas-
sively parallel short-read sequencing has recently been devel-
oped for mapping TFBSs and histone-modification profiles in
mammalian cells (Barski et al., 2007; Johnson et al., 2007; Mik-
kelsen et al., 2007; Robertson et al., 2007). In this study, we per-
formed a large-scale mapping study of multiple TFs in mamma-
lian cells.
Genome-wide mapping studies reveal abundant binding sites
for different TFs in mammalian cells (Bieda et al., 2006; Birney
et al., 2007; Cawley et al., 2004). Although advances in mapping
technologies allow for comprehensive and unbiased disclosure
of the repertoire of binding sites, it is difficult to determine which
sites are functional regulatory elements that influence transcrip-
tion. It is possible that a sizeable fraction of these binding sites
are nonfunctional and are the consequence of biological noise
(Struhl, 2007). It is also important to note that ChIP experiments
may capture indirect TF-DNA interactions through protein-
protein interaction. The strength of our study lies in the concur-rent survey of the locations of multiple TFs in a single cell type.
Our data show that there are genomic regions extensively co-
occupied by TFs (TF colocalization hotspots). These are more
likely to represent functionally important sites.
It is also of interest to note that a recent study has profiled the
binding sites of nine TFs in mouse ES cells (Kim et al., 2008). The
major distinctions between the two studies are the coverage of
the survey and themethod for capturing the TF-DNA complexes.
This study surveyed the whole-genome binding sites of TFs by
using antibodies recognizing endogenous proteins, whereas
Kim and colleagues used promoter DNA microarrays to investi-
gate the occupancies of biotin-tagged proteins. The two studies
also focused on a slightly different set of TFs. For example, this
study analyzed the locations for the downstream effectors of key
signaling pathways (Smad1, STAT3), self-renewal regulators
(Zfx, Esrrb), insulator-binding proteins (CTCF), and two tran-
scriptional coregulators (p300, Suz12). The ChIP-seq method
reveals a richer repertoire of binding sites, as it can identify bind-
ing sites found at repetitive elements. Future work that integrates
these data sets should provide insights into the usage of sites
identified by the two studies.
ES-Cell-Specific Enhanceosomes
An enhanceosome is a nucleoprotein complex composed of dis-
tinct sets of TFs bound directly or indirectly to enhancer DNA
(Thanos and Maniatis, 1995). The density of TFs occurring on
this short segment of DNA is high compared to more ‘‘modular’’
enhancers that have less dense binding clusters occurring over
a longer segment of genomic DNA (Arnosti and Kulkarni,
2005). The virus-inducible enhancer of the interferon-b gene
(IFN-b) is a prototypical enhanceosome. This 55 bp enhancer
is bound by the p50 and p65 subunits of NF-kB, ATF-2, IRF-3,
IRF-7, c-Jun, and the architectural TF HMGA. An atomic model
for the complex of eight of these factors on the DNA has been
constructed based on three crystal structures (Panne et al.,
2007). The basis for cooperativity is unlikely to be mediated
through protein-protein interactions, as these structures reveal
limited contact between the TFs. It is proposed that the binding
of these eight TFs on a composite DNA interface creates a con-
tinuous surface for recruiting coactivators such as p300 (Merika
et al., 1998; Wathelet et al., 1998).
Our genome-wide mapping study reveals genomic regions
with features of enhanceosomes. First, the binding sites are
densely clustered within relatively compact genomic segments.
It is of interest to note that the densest binding locus we identi-
fied is the distal enhancer of Pou5f1. This region (Chew et al.,
2005) was bound by 11 TFs. Second, we showed that 25 of
these genomic regions act as enhancers when placed down-
stream of the luciferase reporter. Third, they are associated
with the H3K4me3 mark, which is one of the signatures of active
genomic regions. Fourth, our p300 ChIP-seq analysis revealed
on a global scale the recruitment of this coactivator to the
Nanog-Oct4-Sox2 cluster, but not the Myc cluster. Importantly,
we showed that the recruitment of p300 is dependent on Oct4,
Sox2, and Nanog.
In higher eukaryotes, transcriptional enhancers play important
roles in integrating multiple signaling pathways to achieve acti-
vation of specific genes. By profiling multiple TFBSs on theCell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc. 1111
Figure 4. Multiple Transcription Factor-Binding Loci Associated with Nanog, Oct4, Sox2, Smad1, and STAT3 as ES-Cell Enhanceosomes
(A) Co-occurrence of transcription factor (TF) groups within MTL. Colors in the heat map reflect the colocalization frequency of each pair of TFs in MTL (yellow
means more frequently colocalized, red means less). TFs have been clustered along both axes based on the similarity in their colocalization with other factors.
(B) Dissection of the TF makeup within MTL. Two major clusters exist within the 3583 MTL. The first group (orange sector) consists of Oct4, Nanog, or Sox2, but
not n-Myc and c-Myc. The second group (light-blue sector) consists of n-Myc or c-Myc, but not Oct4, Nanog, and Sox2. The purple sector is a mixture of the first
two groups (orange and light-blue sectors).1112 Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc.
whole-genome scale, we discovered extensive colocalization of
multiple TFs on selective sites in the ES-cell genome.
Wiring of the ES-Cell Genome
LIF has long been known to be essential for the derivation or
maintenance of mouse ES cells (Smith, 2001). Beside LIF, other
factors in fetal calf serum could be essential for the self-renewal
of mouse ES cells. Smith and coworkers have identified BMPs as
growth factors that work in conjunction with LIF to promote self-
renewal (Ying et al., 2003). The addition of BMP4 to chemically
definedmedia leads to the phosphorylation of Smad1 in ES cells.
As constitutive expression of the Id genes bypasses the BMP4 or
fetal calf serum requirement for maintenance of ES cells, the Id
genes are implicated as downstream targets of the BMP/Smad
signaling pathway (Ying et al., 2003). ES cells can be passaged
without differentiation with LIF and BMP4, indicating that the
pathways induced by these two ligands are sufficient to maintain
stem cells. Importantly, we showed here that the binding of
STAT3 and Smad1 to genomic sites is dependent on the LIF
and BMP pathways, respectively, confirming the importance of
these TFs as effectors of the signal transduction pathways that
maintain pluripotency in ES cells (Figures S3L and S3M). Until
the present study, the roles of transcriptional regulatory proteins
downstream of these signaling pathways have not been well
defined in the context of ES-cell transcriptional regulatory net-
works. STAT3 had been shown to bind to the Nanog enhancer
(Suzuki et al., 2006), but there were no known targets of Smad1.
Consistent with a previous study implicating Id genes as
downstream targets of the BMP4 pathway (Ying et al., 2003),
we identified a MTL (bound by Smad1, Oct4, Sox2, Nanog,
Klf4, E2f1, Esrrb, and Tcfcp2l1) 1.5 kb upstream of the TSS of
Id3. Strikingly, the majority (97.3%, 649/667) of Smad1 at the
MTL is associated with Nanog, Oct4, or Sox2. STAT3 (72.5%,
521/718) is also predominantly localized with Nanog, Oct4, or
Sox2 within the MTL.
Themultiple TFBSmaps provide us with the opportunity to ex-
amine the mode of targeting genes by these factors on a global
scale. E2f1 binds to 50% of all genes, almost all of which fall
into what we call classes I, II, and III (Figure 6A). Genes in these
three classes (I, II, and III) are expressed at higher levels in ES
cells than are genes in the other classes (Figure 6C), and class
I and class II are enriched in genes that are expressed at higher
levels in ES cells than in differentiating cells. Roughly 50% of all
genes, those in classes IV and V, are not enriched in TF binding
(Figure 6A). These TF-deficient genes are not expressed or are
expressed at a low level. A fraction of these genes are boundby Suz12, suggesting that Suz12 plays a role in preventing TF
occupancy and in silencing these genes (Boyer et al., 2006;
Lee et al., 2006). However, a larger fraction of the TF-deficient
genes are not bound by Suz12. It is possible that the chromatin
structure of these genes is not permissive to the binding of TFs.
In summary, the genome-wide maps of TFs and coregulators
demarcate different gene compartments in the ES-cell genome.
The densely co-occupied sites represent key regions of potential
functional importance and will assist in the identification of new
regulators of self-renewal, pluripotency, and reprogramming.
We demonstrate that the two key signaling pathways are inte-
grated to the Oct4, Sox2, and Nanog circuitries through
Smad1 and STAT3. Our data also provide a framework for mod-
eling gene expression and understanding the transcriptional
regulatory networks in pluripotent cells.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
E14mouse ES cells, cultured under feeder-free conditions, weremaintained in
Dulbecco’s modified Eagle’s medium (DMEM, GIBCO-BRL), with 15% heat-
inactivated ES-qualified fetal bovine serum (FBS, GIBCO-BRL), 0.055 mM b-
mercaptoethanol (GIBCO-BRL), 2mM L-glutamine, 0.1 mMMEMnonessential
amino acid, 5000 U/ml penicillin/streptomycin, and 1000 U/ml LIF (Chemicon).
293T cells were cultured in DMEMwith 10% FBS and maintained at 37C with
5% CO2. For serum-free cell cultures, feeder-free E14 mouse ES cells were
plated onto gelatin-coated plates in ESGRO Complete Basal Medium (Chem-
icon) supplementedwith 10 ng/ml LIF (Chemicon) and 50 ng/ml BMP4 (Sigma).
Cells were passaged every 2–3 days using accutase (GIBCO-BRL).
Oct4, Sox2, and Nanog shRNA constructs were designed as described
previously (Loh et al., 2006). Transfection of shRNA was performed by using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.
For the ChIP assay, 35 mg plasmids were transfected into ES cells on 150
mm plates. Puromycin (Sigma) selection was introduced 1 day after transfec-
tion at 1.0 mg/ml, and the cells were crosslinked and harvested 48 hr after
transfection.
Luciferase Assay
For the 25 Nanog-Oct4-Sox2 cluster fragments and 8 Myc cluster fragments
tested for enhancer activity, the fragments (300 bp) were amplified from ge-
nomic DNA and cloned into BamHI and SalI sites of pGL3-Pou5f1 pp vector (a
Pou5f1minimal promoter driving luciferase) and sequence verified. E14mouse
ES cells or 293T cells were transfected with these reporter constructs by using
Lipofectamine 2000 (Invitrogen). A Renilla luciferase plasmid (pRL-SV40 from
Promega) was cotransfected as an internal control. Cells were harvested 36 hr
after transfection, and the luciferase activities of the cell lysates were mea-
sured by using the Dual-luciferase Reporter Assay System (Promega).
ChIP Assay
AChIP assay was carried out as described previously (Loh et al., 2006). Briefly,
cells were crosslinked with 1% formaldehyde for 10 min at room temperature,(C) The occurrence of the other TFs (Smad1, STAT3, Esrrb, Tcfcp2l1, Klf4, Zfx, CTCF, and E2f1) within the 3583 MTL. The color legend is the same as in (B).
(D) Genomic fragments associated with the Nanog-Oct4-Sox2 cluster show enhancer activity. A genomic fragment of300 bp (shown in red) was cloned down-
stream of a luciferase reporter (shown in blue) driven by minimal Pou5f1 promoter (shown in orange). These reporter constructs were transfected into ES cells or
293T cells to determine ES-cell-specific enhancer activity. The loci tested for enhancer activity and primers for cloning these genomic fragments are listed in
Table S9. Ten of the 25 Nanog-Oct4-Sox2 loci (40%) are marked with H3K4me3, whereas all 8 of the Myc loci are marked with H3K4me3.
(E) Smad1 occupancy is dependent on Oct4. ChIP assays were performed by using the anti-Smad1 antibody with extracts from ES cells transfected with the
control RNAi construct (yellow bar) or the Oct4 RNAi construct (blue bar).
(F) STAT3 occupancy is dependent on Oct4. ChIP assays were performed by using the anti-STAT3 antibody with extracts from ES cells transfected with the con-
trol RNAi construct (yellow bar) or the Oct4 RNAi construct (blue bar).
(G) Oct4 occupancy is not dependent on the LIF and BMP pathways. ChIP assays were performed by using the anti-Oct4 antibody with extracts from ES cells
treated with LIF+BMP4 (orange bar), LIF alone (green bar), BMP4 alone (blue bar), or no LIF and BMP4 (gray bar). Coordinates and q-PCR primers of the loci
tested in (E)–(G) are listed in Table S10. All data are presented as mean ± SEM.Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc. 1113
Figure 5. p300 Is Recruited to the Nanog-Oct4-Sox2 Cluster
(A) p300 is associated with the Nanog-Oct4-Sox2 cluster, but not with the Myc cluster. The pie chart shows the occurrence of p300 in different MTL types. The
color legend is the same as for Figure 4B.
(B) Size distribution and composition of binding-site groups containing p300. (Top) Histogram showing the number of binding-site groups of different sizes. Size,
here, refers to the number of non-p300 transcription factors (TFs) that have binding sites in the same group. (Bottom) Composition of p300-containing binding-site
groups for different group sizes. Composition is expressed in terms of the percentage of p300-containing groups that contain the indicated TF. For example,
Nanog, Sox2, and Oct4 are each found in 70% or more of the p300-containing clusters that have five other factors bound, whereas Smad1, Esrrb, Klf4, Tcfcp2l1,
and STAT3 are each found at a frequency of 30%–50%.
(C) Motif predicted by the de novo motif-discovery algorithm Weeder.
(D) Recruitment of p300 is dependent on Oct4, Sox2, and Nanog. ChIP assays were performed by using the anti-p300 antibody with extracts from ES cells trans-
fected with the control RNAi construct (gray bar), the Oct4 RNAi construct (orange bar), the Sox2 RNAi construct (blue bar), or the Nanog RNAi construct (green
bar). Coordinates of loci and q-PCR primers are listed in Table S10. The level of p300 was not altered after RNAi depletion of these TFs (data not shown). Data are
presented as mean ± SEM.and formaldehyde was then inactivated by the addition of 125 mM glycine.
Chromatin extracts containing DNA fragments with an average size of 500
bp were immunoprecipitated by using the antibodies shown in Table S1. All
ChIP experiments were repeated at least three times.
Computational Analyses
To identify the MTL, a list of genomic sites co-bound by any of the 13 TFs was
generated. Two binding regions were clustered if their centers were 100 bp
apart at most. This clustering procedure was done iteratively to form the larg-
est possible clusters, forming what we call MTL. ChIP-seq data sets for p300
and Suz12 were also generated to determine where these coregulators are
recruited with respect to the TFs profiled. Distances from one coregulator1114 Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc.site to the nearest TFBSs were then calculated. Pairs of sites within 50 bp of
one another were considered to belong to the same group. We computed
the Pearson correlation coefficient for each pair of such colocalization vectors
and used it as a similarity measure to cluster these factors. To associate bind-
ing site information with gene expression, we computed an association score
for each pair of gene and TF based on the relative distance to the TSS of the
gene. We then performed k-mean clustering on an association matrix to group
the genes with similar TF association. Gene groups by this method were then
analyzed with a previously published RA-induced differentiation data set (Iva-
nova et al., 2006).
Two published sets of gene-expression experiments were used in combina-
tion with the ChIP-seq data reported here to obtain a set of genes that are
Figure 6. Association between Transcription Factor Binding and Gene Expression in ES Cells
(A) Heatmap showing five classes of genes obtained from k-means clustering based on the transcription factor (TF)-gene association score. In this analysis, we
included a Suz12 ChIP-seq data set to explore the potential association of Suz12 and the other 13 TFs.
(B) Enrichment of TFs in the five classes. The y axis represents the ratio of the average TF-gene association score for the group to the average association score
for all genes.
(C) Histogram of the levels of gene expression for genes found in each of the five classes.
(D) Proportion of different classes of genes found in differentially (up- or downregulated in ES cells) and nondifferentially expressed genes in a published expres-
sion data set (Ivanova et al., 2006).enriched in direct transcriptional targets (Ivanova et al., 2006; Zhou et al.,
2007). For a given TF, we scored and ranked each gene based on the number
and ‘‘intensity’’ of ChIP-seq-defined binding sites. For a given expression
change ranking and a given TF-binding ranking, we used responder analysis
to determine the significance of association between binding and expression,
as well as to define gene sets that are at least 2-fold enriched in direct targets.
Regulatory targets were inferred from the intersection of top-ranked bound
genes and top-ranked differentially expressed genes. Further details are avail-
able in the Supplemental Data.ACCESSION NUMBERS
Our ChIP-seq datasets have been deposited in the GEO database with ID
number GSE11431.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental Results, Supplemental Discussion, fifteen figures, fourteen tables,Cell 133, 1106–1117, June 13, 2008 ª2008 Elsevier Inc. 1115
and Supplemental References and are available at http://www.cell.com/cgi/
content/full/133/6/1106/DC1/.
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